{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T11:18:40Z","timestamp":1791631120672,"version":"4.3.4"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Government of India Department of Biotechnology","doi-asserted-by":"publisher","award":["BT\/PR40226\/BTIS\/137\/66\/2023"],"award-info":[{"award-number":["BT\/PR40226\/BTIS\/137\/66\/2023"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bioorg.2024.107773","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:13:45Z","timestamp":1725322425000},"page":"107773","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Fluoroquinolones tackling antimicrobial resistance: Rational design, mechanistic insights and comparative analysis of norfloxacin vs ciprofloxacin derivatives"],"prefix":"10.1016","volume":"153","author":[{"given":"Aanchal","family":"Khanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1257-0054","authenticated-orcid":false,"given":"Nitish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupali","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Jyoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anchal","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Muskan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harmandeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preet Mohinder Singh","family":"Bedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.bioorg.2024.107773_b0005","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1039\/C7RA13661G","article-title":"Promising bactericidal approach of dihydrazone analogues against bio-film forming Gram-negative bacteria and molecular mechanistic studies","volume":"8","author":"Rakesh","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2024.107773_b0010","series-title":"Silver Micro-Nanoparticles-Properties, Synthesis, Characterization, and Applications","article-title":"Silver nanoparticles impregnated wound dressings: recent progress and future challenges","author":"Singh","year":"2021"},{"key":"10.1016\/j.bioorg.2024.107773_b0015","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1134\/S1068162018020036","article-title":"Effect of low charge and high hydrophobicity on antimicrobial activity of the quinazolinone-peptide conjugates","volume":"44","author":"Rakesh","year":"2018","journal-title":"Russ. J. Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107773_b0020","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.micpath.2018.07.025","article-title":"Role of BP* C@ AgNPs in Bap-dependent multicellular behavior of clinically important methicillin-resistant Staphylococcus aureus (MRSA) biofilm adherence: a key virulence study","volume":"123","author":"Zhang","year":"2018","journal-title":"Microb. Pathog."},{"issue":"12","key":"10.1016\/j.bioorg.2024.107773_b0025","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1039\/C7MD00486A","article-title":"Novel TC@ AgNPs mediated biocidal mechanism against biofilm associated methicillin-resistant Staphylococcus aureus (Bap-MRSA) 090, cytotoxicity and its molecular docking studies","volume":"8","author":"Manukumar","year":"2017","journal-title":"MedChemComm."},{"key":"10.1016\/j.bioorg.2024.107773_b0030","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bioorg.2018.08.024","article-title":"Multi-targeted dihydrazones as potent biotherapeutics","volume":"81","author":"Li","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2024.107773_b0035","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1021\/acscombsci.8b00088","article-title":"Combating a master manipulator: Staphylococcus aureus immunomodulatory molecules as targets for combinatorial drug discovery","volume":"20","author":"Rakesh","year":"2018","journal-title":"ACS Comb. Sci."},{"issue":"10325","key":"10.1016\/j.bioorg.2024.107773_b0040","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2024.107773_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2020.100067","article-title":"Multi-targeted quinazolinone-Schiff's bases as potent bio-therapeutics","volume":"2","author":"Ullas","year":"2020","journal-title":"Results Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107773_b0050","doi-asserted-by":"crossref","first-page":"e516","DOI":"10.1016\/S2214-109X(23)00554-5","article-title":"Antimicrobial resistance and the great divide: inequity in priorities and agendas between the Global North and the Global South threatens global mitigation of antimicrobial resistance","volume":"12","author":"Mendelson","year":"2024","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.bioorg.2024.107773_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.procbio.2023.10.024","article-title":"Triazole derivatives as potential antifungal agents: a structure-activity relationship (SAR) studies","author":"Hu","year":"2023","journal-title":"Process Biochem."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107773_b0060","doi-asserted-by":"crossref","first-page":"254","DOI":"10.5155\/eurjchem.6.3.254-260.1233","article-title":"Quinazolinones linked amino acids derivatives as a new class of promising antimicrobial, antioxidant and anti-inflammatory agents","volume":"6","author":"Rakesh","year":"2015","journal-title":"Eur. J. Chem."},{"key":"10.1016\/j.bioorg.2024.107773_b0065","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.micres.2018.05.002","article-title":"Master mechanisms of Staphylococcus aureus: consider its excellent protective mechanisms hindering vaccine development!","volume":"212","author":"Zhang","year":"2018","journal-title":"Microbiol. Res."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107773_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics12030625","article-title":"A comprehensive review on chemical synthesis and chemotherapeutic potential of 3-heteroaryl fluoroquinolone hybrids","volume":"12","author":"Hryhoriv","year":"2023","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107773_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2023.108511","article-title":"Quinoline-based anti-MRSA agents: current development, structure-activity relationships, and mechanisms","volume":"35","author":"Yao","year":"2024","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107773_b0080","first-page":"1","article-title":"Molecular modeling, dynamic simulation, and metabolic reactivity studies of quinazoline derivatives to investigate their anti-angiogenic potential by targeting wild EGFRwt and mutant EGFRT790M receptor tyrosine kinases","author":"Shah","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2024.107773_b0085","series-title":"Recent Development of Quinoline Derivatives as Anticancer Agents: 2015\u20132022. Cancer Treatment: An Interdisciplinary Approach","first-page":"217","author":"Kaur","year":"2023"},{"issue":"4","key":"10.1016\/j.bioorg.2024.107773_b0090","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s11030-022-10537-y","article-title":"Quinoline derivatives volunteering against antimicrobial resistance: rational approaches, design strategies, structure activity relationship and mechanistic insights","volume":"27","author":"Kumar","year":"2023","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bioorg.2024.107773_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136791","article-title":"Synthesis of novel pyrrolo [1, 2-a] quinoline derivatives as a new class of anti-inflammatory and antimicrobial agents: an approach to single crystal X-ray structure, Hirshfeld surface analysis and DFT studies","volume":"1296","author":"Patil","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2024.107773_b0100","article-title":"Synthesis, spectral analysis, DFT calculations, in vitro screening, and molecular docking of new metal complexes with quinoline and isoniazid Schiff base as antimicrobial and antioxidant agents","author":"Nalini","year":"2023","journal-title":"Polycycl. Aromat. Compd."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107773_b0105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/10406638.2023.2169471","article-title":"New quinoline analogues: as potential diabetics inhibitors and molecular docking study","volume":"44","author":"Taha","year":"2024","journal-title":"Polycycl. Aromat. Compd."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107773_b0110","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1469-0691.2005.01131.x","article-title":"Quinolones in 2005: an update","volume":"11","author":"Van Bambeke","year":"2005","journal-title":"Clin. Microbiol. Infect."},{"issue":"12","key":"10.1016\/j.bioorg.2024.107773_b0115","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1021\/jm501881c","article-title":"Origins of the quinolone class of antibacterials: an expanded \u201cdiscovery story\u201d miniperspective","volume":"58","author":"Bisacchi","year":"2015","journal-title":"J. Med. Chem."},{"issue":"23","key":"10.1016\/j.bioorg.2024.107773_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26237153","article-title":"Biological effects of quinolones: a family of broad-spectrum antimicrobial agents","volume":"26","author":"Millanao","year":"2021","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107773_b0125","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s11030-022-10581-8","article-title":"Quinolone: a versatile therapeutic compound class","volume":"27","author":"Dube","year":"2023","journal-title":"Mol. Divers."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107773_b0130","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/14756360903373350","article-title":"Ciprofloxacin: review on developments in synthetic, analytical, and medicinal aspects","volume":"25","author":"Sharma","year":"2010","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107773_b0135","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pmrj.2010.10.003","article-title":"Musculoskeletal complications of fluoroquinolones: guidelines and precautions for usage in the athletic population","volume":"3","author":"Hall","year":"2011","journal-title":"PM&R"},{"key":"10.1016\/j.bioorg.2024.107773_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2022.103142","article-title":"Combination of photodynamic antimicrobial chemotherapy and ciprofloxacin to combat S. aureus and E. coli resistant biofilms","volume":"42","author":"Openda","year":"2023","journal-title":"Photodiagn. Photodyn. Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107773_b0145","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12914-y","article-title":"Cryo-EM structure of the complete E. coli DNA gyrase nucleoprotein complex","volume":"10","author":"Vanden Broeck","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2024.107773_b0150","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.86722","article-title":"DNA-induced interface swapping by DNA gyrase","volume":"12","author":"Germe","year":"2024","journal-title":"Elife"},{"issue":"10","key":"10.1016\/j.bioorg.2024.107773_b0155","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1073\/pnas.75.10.4838","article-title":"Energy coupling in DNA gyrase and the mechanism of action of novobiocin","volume":"75","author":"Sugino","year":"1978","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2024.107773_b0160","article-title":"In silico analysis of ciprofloxacin analogs as inhibitors of DNA gyrase of Staphylococcus aureus","volume":"26","author":"Hasan","year":"2021","journal-title":"Inf. Med. Unlocked"},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2024.107773_b0165","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mrfmmm.2007.06.009","article-title":"DNA topoisomerase II, genotoxicity, and cancer","volume":"623","author":"McClendon","year":"2007","journal-title":"Mutat. Res.\/Fund. Mol. Mech. Mutagen."},{"issue":"22","key":"10.1016\/j.bioorg.2024.107773_b0170","doi-asserted-by":"crossref","first-page":"7773","DOI":"10.1128\/JB.187.22.7773-7783.2005","article-title":"A gyrase mutant with low activity disrupts supercoiling at the replication terminus","volume":"187","author":"Pang","year":"2005","journal-title":"J. Bacteriol."},{"issue":"10","key":"10.1016\/j.bioorg.2024.107773_b0175","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1128\/AAC.40.10.2252","article-title":"ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype","volume":"40","author":"Munoz","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2024.107773_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.117004","article-title":"New potent ciprofloxacin-uracil conjugates as DNA gyrase and topoisomerase IV inhibitors against methicillin-resistant Staphylococcus aureus","volume":"73","author":"Samir","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107773_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136810","article-title":"Design, synthesis and docking studies of ciprofloxacin analogues as potential antimicrobial agents against resistant pathogens","volume":"1295","author":"Rehman","year":"2024","journal-title":"J. Mol. Struct."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107773_b0190","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ijantimicag.2010.11.022","article-title":"Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates","volume":"37","author":"Bansal","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107773_b0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032879","article-title":"Role of the water-metal ion bridge in quinolone interactions with Escherichia coli gyrase","volume":"24","author":"Carter","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107773_b0200","article-title":"Fluoroquinolones: neurological complications and side effects in clinical practice","volume":"16","author":"Anwar","year":"2024","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107773_b0205","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.49353","article-title":"Association of appropriate empirical antimicrobial therapy with in-hospital mortality in patients with bloodstream infections in the US","volume":"6","author":"Ohnuma","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"16","key":"10.1016\/j.bioorg.2024.107773_b0210","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28166018","article-title":"Fluoroquinolone analogs, SAR analysis, and the antimicrobial evaluation of 7-benzimidazol-1-yl-fluoroquinolone in in vitro, in silico, and in vivo models","volume":"28","author":"Medell\u00edn-Luna","year":"2023","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.bioorg.2024.107773_b0215","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics6040026","article-title":"Ubiquitous nature of fluoroquinolones: the oscillation between antibacterial and anticancer activities","volume":"6","author":"Idowu","year":"2017","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107773_b0220","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/AAC.00722-08","article-title":"Relationships among ciprofloxacin, gatifloxacin, levofloxacin, and norfloxacin MICs for fluoroquinolone-resistant Escherichia coli clinical isolates","volume":"53","author":"Becnel Boyd","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.bioorg.2024.107773_b0225","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1128\/AAC.00647-07","article-title":"Contributions of the combined effects of topoisomerase mutations toward fluoroquinolone resistance in Escherichia coli","volume":"51","author":"Morgan-Linnell","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107773_b0230","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nm1347","article-title":"Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase","volume":"12","author":"Robicsek","year":"2006","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.bioorg.2024.107773_b0235","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1128\/AAC.00339-07","article-title":"New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate","volume":"51","author":"Yamane","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2024.107773_b0240","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0021-9673(98)00274-X","article-title":"Analysis of fluoroquinolones in biological fluids by high-performance liquid chromatography","volume":"812","author":"Carlucci","year":"1998","journal-title":"J. Chromatogr. A"},{"issue":"6","key":"10.1016\/j.bioorg.2024.107773_b0245","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1021\/acsbiomedchemau.3c00038","article-title":"N4-substituted piperazinyl norfloxacin derivatives with broad-spectrum activity and multiple mechanisms on gyrase, topoisomerase IV, and bacterial cell wall synthesis","volume":"3","author":"Kamal El-sagheir","year":"2023","journal-title":"ACS Bio Med. Chem. Au."},{"key":"10.1016\/j.bioorg.2024.107773_b0250","doi-asserted-by":"crossref","DOI":"10.4178\/epih\/e2014022","article-title":"Efflux-mediated resistance identified among norfloxacin resistant clinical strains of group B Streptococcus from South Korea","author":"Dang","year":"2014","journal-title":"Epidemiol. Health"},{"key":"10.1016\/j.bioorg.2024.107773_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112513","article-title":"Design, synthesis and antimicrobial evaluation of novel glycosylated-fluoroquinolones derivatives","volume":"202","author":"Mohammed","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107773_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.137916","article-title":"Characterization, molecular docking, and antimicobial activities of some new sulfur containing norfloxacin analogues","author":"El-Saghier","year":"2024","journal-title":"J. Mol. Struct."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107773_b0265","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1128\/AAC.23.1.15","article-title":"Antibacterial activity of norfloxacin","volume":"23","author":"Norrby","year":"1983","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2024.107773_b0270","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejmech.2019.01.072","article-title":"Design and synthesis of aminothiazolyl norfloxacin analogues as potential antimicrobial agents and their biological evaluation","volume":"167","author":"Wang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107773_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.104966","article-title":"Design and synthesis of new norfloxacin-1, 3, 4-oxadiazole hybrids as antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"136","author":"Guo","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2024.107773_b0280","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejmech.2013.06.045","article-title":"Microwave assisted synthesis of some hybrid molecules derived from norfloxacin and investigation of their biological activities","volume":"67","author":"Mentese","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107773_b0285","series-title":"Hot Topics in Infection and Immunity in Children VI","first-page":"73","article-title":"The use and abuse of antibiotics and the development of antibiotic resistance","author":"English","year":"2010"},{"key":"10.1016\/j.bioorg.2024.107773_b0290","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ejmech.2018.01.078","article-title":"Ciprofloxacin derivatives and their antibacterial activities","volume":"146","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107773_b0295","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1155\/1999\/378394","article-title":"The new fluoroquinolones: a critical review","volume":"10","author":"Zhanel","year":"1999","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"10.1016\/j.bioorg.2024.107773_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112001","article-title":"An asymmetric electrospun membrane for the controlled release of ciprofloxacin and FGF-2: evaluation of antimicrobial and chemoattractant properties","volume":"123","author":"Federico","year":"2021","journal-title":"Mater. Sci. Eng. C"},{"issue":"6","key":"10.1016\/j.bioorg.2024.107773_b0305","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.2165\/00003495-199651060-00010","article-title":"Ciprofloxacin: an updated review of its pharmacology, therapeutic efficacy and tolerability","volume":"51","author":"Davis","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.bioorg.2024.107773_b0310","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.1025633","article-title":"The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic","volume":"10","author":"Shariati","year":"2022","journal-title":"Front. Public Health"},{"issue":"8","key":"10.1016\/j.bioorg.2024.107773_b0315","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.tim.2014.04.007","article-title":"Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success","volume":"22","author":"Redgrave","year":"2014","journal-title":"Trends Microbiol."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107773_b0320","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1128\/AAC.48.6.1948-1952.2004","article-title":"Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis","volume":"48","author":"Dajcs","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107773_b0325","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.297","article-title":"Adverse reactions to fluoroquinolones in the Nigerian population: an audit of reports submitted to the National Pharmacovigilance Centre from 2004 to 2016","volume":"5","author":"Oreagba","year":"2017","journal-title":"Pharmacol. Res. Perspect."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107773_b0330","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1751-7915.2008.00063.x","article-title":"Mechanism of action of and resistance to quinolones","volume":"2","author":"F\u00e0brega","year":"2009","journal-title":"J. Microbial. Biotechnol."},{"key":"10.1016\/j.bioorg.2024.107773_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134049","article-title":"Novel fluoroquinolone hybrids as dual DNA gyrase and urease inhibitors with potential antibacterial activity: design, synthesis, and biological evaluation","volume":"1271","author":"Abdel-Aziz","year":"2023","journal-title":"J. Mol. Struct."},{"issue":"19","key":"10.1016\/j.bioorg.2024.107773_b0340","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28196929","article-title":"Novel fluoroquinolones with possible antibacterial activity in gram-negative resistant pathogens: in silico drug discovery","volume":"28","author":"Coba-Males","year":"2023","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.bioorg.2024.107773_b0345","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1128\/AAC.42.6.1495","article-title":"Mode of action of sulfanilyl fluoroquinolones","volume":"42","author":"Alovero","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.bioorg.2024.107773_b0350","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1016\/j.bmc.2005.04.005","article-title":"Synthesis and antimycobacterial evaluation of certain fluoroquinolone derivatives","volume":"13","author":"Zhao","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107773_b0355","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejmech.2013.07.032","article-title":"Mannich bases of 7-piperazinylquinolones and kojic acid derivatives: synthesis, in vitro antibacterial activity and in silico study","volume":"68","author":"Emami","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107773_b0360","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejmech.2014.04.037","article-title":"Design, synthesis, and evaluation of novel fluoroquinolone\u2013flavonoid hybrids as potent antibiotics against drug-resistant microorganisms","volume":"80","author":"Xiao","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107773_b0365","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejmech.2016.03.086","article-title":"Synthesis and biological evaluation of novel structural hybrids of benzofuroxan derivatives and fluoroquinolones","volume":"116","author":"Chugunova","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107773_b0370","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejmech.2016.01.052","article-title":"Discovery of membrane active benzimidazole quinolones-based topoisomerase inhibitors as potential DNA-binding antimicrobial agents","volume":"111","author":"Zhang","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107773_b0375","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bioorg.2019.01.009","article-title":"Piperazine-azole-fluoroquinolone hybrids: conventional and microwave irradiated synthesis, biological activity screening and molecular docking studies","volume":"85","author":"Mermer","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107773_b0380","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ejmech.2019.06.071","article-title":"Synthesis and biological evaluation of hybrid quinolone-based quaternary ammonium antibacterial agents","volume":"179","author":"Fedorowicz","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107773_b0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131799","article-title":"Conventional and microwave irradiated synthesis, biological activity evaluation of highly substituted indole-triazole hybrids","volume":"1250","author":"Cebeci","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2024.107773_b0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134507","article-title":"Novel ciprofloxacin and norfloxacin-tetrazole hybrids as potential antibacterial and antiviral agents: targeting S. aureus topoisomerase and SARS-CoV-2-MPro","volume":"1274","author":"Cardoso-Ortiz","year":"2023","journal-title":"J. Mol. Struct."},{"issue":"20","key":"10.1016\/j.bioorg.2024.107773_b0395","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1016\/j.bmcl.2005.07.016","article-title":"Synthesis and antibacterial activity of N-(5-benzylthio-1, 3, 4-thiadiazol-2-yl) and N-(5-benzylsulfonyl-1, 3, 4-thiadiazol-2-yl) piperazinyl quinolone derivatives","volume":"15","author":"Foroumadi","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107773_b0400","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijantimicag.2006.02.013","article-title":"Antibacterial evaluation of a collection of norfloxacin and ciprofloxacin derivatives against multiresistant bacteria","volume":"28","author":"Vila","year":"2006","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"8","key":"10.1016\/j.bioorg.2024.107773_b0405","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.ejmech.2006.03.027","article-title":"Synthesis, antibacterial and antitubercular activities of some 7-[4-(5-amino-[1, 3, 4] thiadiazole-2-sulfonyl)-piperazin-1-yl] fluoroquinolonic derivatives","volume":"41","author":"Talath","year":"2006","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107773_b0410","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/BF02977685","article-title":"Synthesis and antibacterial activity of N-[5-chlorobenzylthio-1, 3, 4-thiadiazol-2-yl] piperazinyl quinolone derivatives","volume":"30","author":"Foroumadi","year":"2007","journal-title":"Arch. Pharm. Res."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107773_b0415","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.bmcl.2010.12.073","article-title":"Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-5-amino\/methylaminopiperidin-1-yl) fluoroquinolone derivatives","volume":"21","author":"Zhang","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"11","key":"10.1016\/j.bioorg.2024.107773_b0420","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1016\/j.bmcl.2011.04.002","article-title":"Design, synthesis and in vitro antibacterial activity of 7-(4-alkoxyimino-3-aminomethylpiperidin-1-yl) fluoroquinolone derivatives","volume":"21","author":"Chai","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107773_b0425","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ica.2011.01.060","article-title":"First example of well-characterized Re and 99mTc tricarbonyl complexes of ciprofloxacin and norfloxacin in the development of infection-specific imaging agents","volume":"370","author":"Kyprianidou","year":"2011","journal-title":"Inorg. Chim. Acta"},{"issue":"11","key":"10.1016\/j.bioorg.2024.107773_b0430","doi-asserted-by":"crossref","first-page":"5487","DOI":"10.1016\/j.ejmech.2011.09.011","article-title":"Design, synthesis and antibacterial activity of fluoroquinolones containing bulky arenesulfonyl fragment: 2D-QSAR and docking study","volume":"46","author":"Alaa","year":"2011","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107773_b0435","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1039\/c3nj01243c","article-title":"Phosphine derivatives of ciprofloxacin and norfloxacin, a new class of potential therapeutic agents","volume":"38","author":"Bykowska","year":"2014","journal-title":"New J. Chem."},{"issue":"98","key":"10.1016\/j.bioorg.2024.107773_b0440","doi-asserted-by":"crossref","first-page":"80804","DOI":"10.1039\/C5RA07483E","article-title":"Coordination versatility of phosphine derivatives of fluoroquinolones. new Cu I and Cu II complexes and their interactions with DNA","volume":"5","author":"Bykowska","year":"2015","journal-title":"RSC Adv."},{"issue":"12","key":"10.1016\/j.bioorg.2024.107773_b0445","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1002\/jhet.3336","article-title":"Microwave-assisted synthesis, antioxidant, and antimicrobial evaluation of piperazine-azole-fluoroquinolone based 1, 2, 4-triazole derivatives","volume":"55","author":"Ozdemir","year":"2018","journal-title":"J. Heterocycl. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2024.107773_b0450","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.bmcl.2018.03.085","article-title":"Design, synthesis, and evaluation of novel N-1 fluoroquinolone derivatives: probing for binding contact with the active site tyrosine of gyrase","volume":"28","author":"Towle","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107773_b0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2020.111124","article-title":"Antibacterial activity and action mode of Cu (I) and Cu (II) complexes with phosphines derived from fluoroquinolone against clinical and multidrug-resistant bacterial strains","volume":"210","author":"Guz-Regner","year":"2020","journal-title":"J. Inorg. Biochem."},{"issue":"5","key":"10.1016\/j.bioorg.2024.107773_b0460","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/jhet.4430","article-title":"Novel fluoroquinolones containing 2-arylamino-2-oxoethyl fragment: design, synthesis, evaluation of antibacterial and antituberculosis activities and molecular modeling studies","volume":"59","author":"Kulaba\u015f","year":"2022","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.bioorg.2024.107773_b0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128885","article-title":"Pyrimidine-conjugated fluoroquinolones as new potential broad-spectrum antibacterial agents","volume":"73","author":"Tan","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107773_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115798","article-title":"Synthesis and biological evaluation of fluoroquinolones containing a pyridoxine derivatives moiety","volume":"261","author":"Shtyrlin","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107773_b0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115373","article-title":"Antibacterial and antibiofilm activity of permanently ionized quaternary ammonium fluoroquinolones","volume":"254","author":"Fedorowicz","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107773_b0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116107","article-title":"Discovery of benzopyridone cyanoacetates as new type of potential broad-spectrum antibacterial candidates","volume":"265","author":"Zhang","year":"2024","journal-title":"Eur. J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824006783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824006783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T02:20:58Z","timestamp":1738203658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824006783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":96,"alternative-id":["S0045206824006783"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107773","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluoroquinolones tackling antimicrobial resistance: Rational design, mechanistic insights and comparative analysis of norfloxacin vs ciprofloxacin derivatives","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107773","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107773"}}